Cerebrospinal fluid shunting or dural venous sinus stenting to preserve vision in idiopathic intracranial hypertension (IIH Intervention)

Idiopathic intracranial hypertension (IIH) happens when fluid builds up naturally inside the skull, putting extra pressure on the brain and the optic nerves that connect your eyes to your brain. Common symptoms include severe headaches, pulsing noises in the ears, and blurred or double vision. For most people, weight loss and medications manage the condition well. However, for a small number of people, the pressure builds up rapidly and puts their eyesight in serious danger. When this happens, an urgent operation is needed to protect their vision.

At present, UK surgeons usually choose between two different operations. One option is called cerebrospinal fluid (CSF) shunting, where a thin, flexible tube is placed under the skin to safely drain excess brain fluid away to another part of the body. The other option is dural venous sinus stenting, where a specialist guides a tiny wire mesh tube into a narrowed blood vessel in the brain to keep it open. While both operations are already used in NHS hospitals, there is not yet enough clear evidence showing which one protects eyesight better or has fewer complications.

The IIH Intervention study aims to solve this puzzle. By directly comparing the two procedures across NHS hospitals in England, Scotland, and Wales, researchers want to find out which option is safer, more effective at saving sight, and better value for healthcare services. The findings will help future patients receive the most reliable treatment without delay.